109 related articles for article (PubMed ID: 1999338)
1. Characterization of a frequent polymorphism in the coding sequence of the Tp53 gene in colonic cancer patients and a control population.
Olschwang S; Laurent-Puig P; Vassal A; Salmon RJ; Thomas G
Hum Genet; 1991 Feb; 86(4):369-70. PubMed ID: 1999338
[TBL] [Abstract][Full Text] [Related]
2. p53 mutations in colorectal cancer.
Rodrigues NR; Rowan A; Smith ME; Kerr IB; Bodmer WF; Gannon JV; Lane DP
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7555-9. PubMed ID: 1699228
[TBL] [Abstract][Full Text] [Related]
3. Higher frequency of point mutations in the c-K-ras 2 gene in human colorectal adenomas with severe atypia than in carcinomas.
Ando M; Maruyama M; Oto M; Takemura K; Endo M; Yuasa Y
Jpn J Cancer Res; 1991 Mar; 82(3):245-9. PubMed ID: 1708754
[TBL] [Abstract][Full Text] [Related]
4. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers.
Costa A; Marasca R; Valentinis B; Savarino M; Faranda A; Silvestrini R; Torelli G
J Pathol; 1995 May; 176(1):45-53. PubMed ID: 7616356
[TBL] [Abstract][Full Text] [Related]
5. No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients.
Mabrouk I; Baccouche S; El-Abed R; Mokdad-Gargouri R; Mosbah A; Saïd S; Daoud J; Frikha M; Jlidi R; Gargouri A
Ann N Y Acad Sci; 2003 Dec; 1010():764-70. PubMed ID: 15033824
[TBL] [Abstract][Full Text] [Related]
6. Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with colon cancer.
Mojtahedi Z; Mohmedi M; Rahimifar S; Erfani N; Hosseini SV; Ghaderi A
Gene; 2012 Oct; 508(2):229-32. PubMed ID: 22892379
[TBL] [Abstract][Full Text] [Related]
7. p53 Gene mutations in sporadic colorectal carcinoma in Guangxi region.
Gao F; Li C; Li W; Chen L; Tang Z; Tang W
Cancer Invest; 2006 Nov; 24(7):689-95. PubMed ID: 17118779
[TBL] [Abstract][Full Text] [Related]
8. Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population.
Rivu SF; Apu MNH; Shabnaz S; Nahid NA; Islam MR; Al-Mamun MMA; Nahar Z; Rabbi SNI; Ahmed MU; Islam MS; Hasnat A
Cancer Epidemiol; 2017 Aug; 49():46-52. PubMed ID: 28554075
[TBL] [Abstract][Full Text] [Related]
9. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.
Nishisho I; Nakamura Y; Miyoshi Y; Miki Y; Ando H; Horii A; Koyama K; Utsunomiya J; Baba S; Hedge P
Science; 1991 Aug; 253(5020):665-9. PubMed ID: 1651563
[TBL] [Abstract][Full Text] [Related]
10. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
[TBL] [Abstract][Full Text] [Related]
11. [The significance of p53 gene mutations and expressions in human colorectal tumors].
Qian H; Yu B; Zhou X
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):332-5. PubMed ID: 8697968
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer.
Palacio-Rúa KA; Isaza-Jiménez LF; Ahumada-Rodríguez E; Muñetón-Peña CM
Rev Gastroenterol Mex; 2014; 79(2):79-89. PubMed ID: 24861525
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation.
el-Mahdani N; Vaillant JC; Guiguet M; Prévot S; Bertrand V; Bernard C; Parc R; Béréziat G; Hermelin B
Br J Cancer; 1997; 75(4):528-36. PubMed ID: 9052405
[TBL] [Abstract][Full Text] [Related]
14. A comparison of Southern blot and polymerase chain reaction as techniques to identify loss of DNA heterozygosity in colorectal cancer.
Hewett PJ; Firgaira F; Morley A
Aust N Z J Surg; 1994 Aug; 64(8):556-7. PubMed ID: 8048895
[TBL] [Abstract][Full Text] [Related]
15. [p53 gene mutation in cancer of the colon and rectum].
Roa JC; Roa I; Melo A; Araya JC; Villaseca MA; Flores M; Schneider B
Rev Med Chil; 2000 Sep; 128(9):996-1004. PubMed ID: 11349504
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
17. Detection of point mutations of the Axin1 gene in colorectal cancers.
Jin LH; Shao QJ; Luo W; Ye ZY; Li Q; Lin SC
Int J Cancer; 2003 Dec; 107(5):696-9. PubMed ID: 14566817
[TBL] [Abstract][Full Text] [Related]
18. [Association between genetic polymorphism in STK15 and risk of colorectal cancer in a Chinese population].
Zhang WJ; Miao XP; Sun T; Zhang XM; Qu SN; Tan W; Xiong P; Zheng R; Lin DX
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):43-6. PubMed ID: 16737620
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.
Campo E; de la Calle-Martin O; Miquel R; Palacin A; Romero M; Fabregat V; Vives J; Cardesa A; Yague J
Cancer Res; 1991 Aug; 51(16):4436-42. PubMed ID: 1868464
[TBL] [Abstract][Full Text] [Related]
20. [A case-control study on the association between the genetic polymorphism of sulfotransferase 1A1, diet and susceptibility of colorectal cancer].
Chen K; Fan CH; Jin MJ; Song L; Xu H; He HQ; Tong F
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):670-3. PubMed ID: 17274372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
